Logo
x

Search category

Subscribe Now

Anti-TIGIT Bispecific Antibody

BMS Signs an Exclusive Global License with Agenus for its Anti-TIGIT Bispecific Antibody Program

BMS Signs an Exclusive Global License with Agenus for its Anti-TIGIT Bispecific Antibody Program

  • May 19, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.